These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36661299)

  • 1. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system.
    Jean-Pierre F; Hampton TH; Schultz D; Hogan DA; Groleau MC; Déziel E; O'Toole GA
    Elife; 2023 Jan; 12():. PubMed ID: 36661299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes.
    Poirier S; Jean-Pierre F
    J Vis Exp; 2024 Apr; (206):. PubMed ID: 38709077
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
    Law JP; Wood AJ; Friman VP
    Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
    Barraza JP; Whiteley M
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcriptional profiling and genetic analysis of a cystic fibrosis airway-relevant model shows asymmetric responses to growth in a polymicrobial community.
    Kesthely CA; Rogers RR; El Hafi B; Jean-Pierre F; O'Toole GA
    Microbiol Spectr; 2023 Sep; 11(5):e0220123. PubMed ID: 37772884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dpr-mediated H
    Rogers RR; Kesthely CA; Jean-Pierre F; El Hafi B; O'Toole GA
    J Bacteriol; 2024 Jun; ():e0017624. PubMed ID: 38940597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Profiling and Genetic Analysis of a Cystic Fibrosis Airway-Relevant Model Shows Asymmetric Responses to Growth in a Polymicrobial Community.
    Kesthely CA; Rogers RR; Hafi BE; Jean-Pierre F; O'Toole GA
    bioRxiv; 2023 May; ():. PubMed ID: 37293107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
    Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
    Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.
    Scott JE; Li K; Filkins LM; Zhu B; Kuchma SL; Schwartzman JD; O'Toole GA
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30718303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.
    Lopes SP; Azevedo NF; Pereira MO
    Int J Med Microbiol; 2017 Dec; 307(8):460-470. PubMed ID: 29033313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
    Orazi G; Jean-Pierre F; O'Toole GA
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.